Remy Blaire is joined by David Kaplan, Pharmaceuticals Director at S&P Global, to dive into the ongoing legal battles surrounding the Trump administration’s tariff authority, particularly in relation to the pharmaceutical industry. The Court of International Trade recently ruled that Trump’s tariffs, including those on foreign-made pharmaceuticals, are illegal, prompting the Justice Department to appeal.